Derek Chaves Appointed Chief Financial Officer of Corza Medical
11 July 2024 - 12:55PM
UK Regulatory
Derek Chaves Appointed Chief Financial Officer of Corza Medical
WESTWOOD, Mass., July 11, 2024 (GLOBE NEWSWIRE) --
Corza Medical (“Corza” or the “Company”) is proud to announce the
appointment of Derek Chaves as its new Chief Financial Officer
(CFO), effective July 8, 2024. Corza Medical, a rapidly growing
global leader in medical technology and innovative surgical
solutions, is recognized for its comprehensive approach to
excellence in customer service and partnerships. Derek’s
appointment underscores Corza’s commitment to scaling operations
and driving further growth in a complex and dynamic market
landscape.
Derek brings over 25 years of broad experience in finance and
accounting within the medical technologies and life sciences
sectors, including roles of increasing responsibility at C.R. Bard,
later acquired by Becton Dickinson. Most recently, Derek served as
Vice President, Finance for the $3.6B Integrated Diagnostic
Solutions global business unit at Becton Dickinson and previously
held the role of VP, Finance for Becton Dickinson’s global Surgery
business unit.
“Derek’s appointment comes at a pivotal time for Corza Medical
as we have surpassed the half-billion revenue threshold and
continue to innovate and expand our capabilities,” said Gregory T.
Lucier, Corza Medical Executive Chairman. “His global experience in
finance, understanding of the complexities of our industry, and his
proven track record supporting rapid growth while ensuring
operational efficiencies will be instrumental in our future
success.”
“Derek’s deep expertise across medical device and pharmaceutical
operations uniquely qualifies him to drive value creation as we
expand our global footprint and enhance our offerings. He is an
invaluable addition to our executive team,” added Tom Testa, Corza
Medical's Chief Executive Officer.
Derek holds a Bachelor of Science in Business Administration
from Bryant University and a Master of Business Administration from
Charleston Southern University. His comprehensive background and
leadership skills will play a crucial role in Corza Medical’s
ongoing success and mission to deliver cutting-edge solutions to
healthcare professionals worldwide through remarkable service,
trusted performance, and outstanding value.
About Corza Medical
Corza Medical is a leading global manufacturer of innovative
surgical technologies. With a global team of over 3,000 employees
supporting clinicians, distributor-partners, and medical device
companies worldwide, Corza provides healthcare professionals a
platform of surgical technologies with many industry-leading
brands, including Quill® barbed sutures, Sharpoint® Plus and Look™
surgical sutures, Katena® reusable and Blink™ single-use ophthalmic
instruments, Barron corneal transplant devices, Sharpoint®
microsurgical knives, and the TachoSil® fibrin sealant patch. For
more information, please visit www.corza.com.